A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate - Smolen, J S; Agarwal, S K; Ilivanova, E (Ann Rheum Dis, 2017)
et al.